Priorities in the Benefit-Risk Assessment of New Drugs
ADVERSE DRUG REACTIONS AND ACUTE POISONING REVIEWS 3(2): 113-121, Summer 1984
Showing items related by title, author, creator and subject.
Is It Ethical Conducting Placebo-Controlled Clinical Trials as Part of the Development of New Drugs for the Treatment of Major Depressive Disorder? (And II). Benefit/risk Ratio and Informed Consent. Conclusions Lahuerta, Juan; Gracia, Diego; Casas, Miquel; Baca, Enrique (2004-10-30)